Читать книгу Practical Cardiovascular Medicine - Elias B. Hanna - Страница 79

1 115. Hjalmarson Å, Herlitz J, Målek L, et al. Effect on mortality of metoprolol in acute myocardial infarction. Lancet 1981; ii: 823–7.

2 116. Bangalore S, Steg G, Deedwania P, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 2012; 308: 1340–9. REACH registry. Also, FAST MI registry showed similar outcomes (mortality benefit with beta-blockers up to 1 year after MI, not beyond that): Puymirat E, Riant E, Aissaoui N, et al. Beta-blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. BMJ 2016; 354:i4801.

3 117. Goldberger JJ, Bonow RO, Cuffe M, et al. Effect of beta-blocker dose on survival after acute myocardial infarction. J Am Col Cardiol 2015; 66: 1431–41.

4 118. CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385–90.

5 119. PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004; 351: 2058–68. In stable CAD patients with normal EF and SBP 130–140 mmHg, the addition of ACE-I did not improve outcomes furthermore (55% had prior MI).

6 120. SPRINT Research Group. A randomized trial of intensive versus standard blood pressure control. N Engl J Med 2015; 373: 2103–16.

7 121. Wiviott SD, Cannon CP, Morrow DA, et al. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 2005; 46: 1411–16.

8 122. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309–21. EPHESUS trial: Eplerenone was initiated at 3-14 days after MI, but benefit was significant only if initiated at 3-7 days. Improvement in long-term but also 30-day mortality (Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial. Eur J Heart Fail. 2009;11(11):1099-1105)

9 123. Bhatt DL, Cryer BL, Contant CF, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010; 363: 1909–17.